These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
956 related items for PubMed ID: 9726379
1. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Neurosci Lett; 1998 Jul 31; 251(3):205-8. PubMed ID: 9726379 [Abstract] [Full Text] [Related]
2. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Spillantini MG, Goedert M. Ann N Y Acad Sci; 2000 Jul 31; 920():16-27. PubMed ID: 11193145 [Abstract] [Full Text] [Related]
3. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Proc Natl Acad Sci U S A; 1998 May 26; 95(11):6469-73. PubMed ID: 9600990 [Abstract] [Full Text] [Related]
4. TIGAR inclusion pathology is specific for Lewy body diseases. López KLR, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR. Brain Res; 2019 Mar 01; 1706():218-223. PubMed ID: 30267647 [Abstract] [Full Text] [Related]
5. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T. Acta Neuropathol; 2002 Sep 01; 104(3):225-30. PubMed ID: 12172907 [Abstract] [Full Text] [Related]
6. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT. J Neuropathol Exp Neurol; 1998 Apr 01; 57(4):334-7. PubMed ID: 9600226 [Abstract] [Full Text] [Related]
7. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM. Proc Natl Acad Sci U S A; 2003 Feb 18; 100(4):2047-52. PubMed ID: 12576551 [Abstract] [Full Text] [Related]
8. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis. Hishikawa N, Niwa J, Doyu M, Ito T, Ishigaki S, Hashizume Y, Sobue G. Am J Pathol; 2003 Aug 18; 163(2):609-19. PubMed ID: 12875980 [Abstract] [Full Text] [Related]
9. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T, Takahashi H, Wakabayashi K. J Neuropathol Exp Neurol; 2003 Aug 18; 62(8):812-9. PubMed ID: 14503637 [Abstract] [Full Text] [Related]
10. Parkinson's disease and other alpha-synucleinopathies. Goedert M. Clin Chem Lab Med; 2001 Apr 18; 39(4):308-12. PubMed ID: 11388653 [Abstract] [Full Text] [Related]
11. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H. Acta Neuropathol; 1998 Nov 18; 96(5):445-52. PubMed ID: 9829807 [Abstract] [Full Text] [Related]
12. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy. Shoji M, Harigaya Y, Sasaki A, Uéda K, Ishiguro K, Matsubara E, Watanabe M, Ikeda M, Kanai M, Tomidokoro Y, Shizuka M, Amari M, Kosaka K, Nakazato Y, Okamoto K, Hirai S. J Neurol Neurosurg Psychiatry; 2000 May 18; 68(5):605-8. PubMed ID: 10766891 [Abstract] [Full Text] [Related]
13. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores. Bayer TA, Jäkälä P, Hartmann T, Havas L, McLean C, Culvenor JG, Li QX, Masters CL, Falkai P, Beyreuther K. Neurosci Lett; 1999 May 14; 266(3):213-6. PubMed ID: 10465711 [Abstract] [Full Text] [Related]
14. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. Neurosci Lett; 1998 Jun 19; 249(2-3):180-2. PubMed ID: 9682846 [Abstract] [Full Text] [Related]
15. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Science; 2000 Nov 03; 290(5493):985-9. PubMed ID: 11062131 [Abstract] [Full Text] [Related]
16. The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease. Campbell BC, McLean CA, Culvenor JG, Gai WP, Blumbergs PC, Jäkälä P, Beyreuther K, Masters CL, Li QX. J Neurochem; 2001 Jan 03; 76(1):87-96. PubMed ID: 11145981 [Abstract] [Full Text] [Related]
18. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Højrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, Jensen PH. J Biol Chem; 2005 Feb 18; 280(7):5703-15. PubMed ID: 15590652 [Abstract] [Full Text] [Related]
19. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Brain; 2010 Jan 18; 133(Pt 1):172-88. PubMed ID: 19903734 [Abstract] [Full Text] [Related]
20. Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies. Piao YS, Mori F, Hayashi S, Tanji K, Yoshimoto M, Kakita A, Wakabayashi K, Takahashi H. Acta Neuropathol; 2003 Apr 18; 105(4):403-9. PubMed ID: 12624794 [Abstract] [Full Text] [Related] Page: [Next] [New Search]